<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="A Robust Emphysema Severity Measure Based on Disease Subtypes" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/a-robust-emphysema-severity-measure-based-on-disease-subtypes/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/a-robust-emphysema-severity-measure-based-on-disease-subtypes/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="A Robust Emphysema Severity Measure Based on Disease Subtypes" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-03-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"A Robust Emphysema Severity Measure Based on Disease Subtypes","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/a-robust-emphysema-severity-measure-based-on-disease-subtypes/"},"url":"https://clinicaltree.github.io/posts/a-robust-emphysema-severity-measure-based-on-disease-subtypes/"}</script><title>A Robust Emphysema Severity Measure Based on Disease Subtypes | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>A Robust Emphysema Severity Measure Based on Disease Subtypes</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>A Robust Emphysema Severity Measure Based on Disease Subtypes</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1459443600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Rola Harmouche PhD</a> </em>, <em> <a href="">James C. Ross PhD</a> </em>, <em> <a href="">Alejro A. Diaz MD MPH</a> </em>, <em> <a href="">George R. Washko MMSc MD</a> </em>, <em> <a href="">Raul San Jose Estepar PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1905 words"> <em>10 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We propose a novel single index for the quantification of emphysema severity based on an aggregation of multiple computed tomographic features evident in the lung parenchyma of smokers. Our goal was to demonstrate that this single index provides complementary information to the current standard measure of emphysema, percent emphysema (percent low attenuation areas [ <em>LAA</em> %]), and may be superior in its association with clinically relevant outcomes.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The inputs to our algorithm were objective assessments of multiple emphysema subtypes (normal tissue; panlobular; paraseptal; and mild, moderate, and severe centrilobular emphysema). We applied dimensionality reduction techniques to the emphysema quantities to find a space that maximizes the variance of these subtypes. A single emphysema severity index was then derived from a parametrization of the reduced space, and the clinical utility of the measure was explored in a large cross-sectional cohort of 8914 subjects from the COPDGene Study.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>There was a statistically significant association between the severity index and the <em>LAA</em> %. Subjects with more severe chronic obstructive pulmonary disease (higher Global initiative for Obstructive Lung Disease stage) tended to have a higher computed tomography severity index. Finally, the severity index was associated with clinical outcomes such as lung function and provided a stronger association to these measures than the <em>LAA</em> %.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The method provides a single clinically relevant index that can assess the severity of emphysema and that provides information that is complimentary to the more commonly used <em>LAA</em> %.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Chronic obstructive pulmonary disease (COPD) is characterized by emphysematous destruction of the lung parenchyma. Objective quantification of this process is an important part of disease characterization. Standard methods to do this are based upon a densitometric assessment of the lung parenchyma where a Hounsfield unit threshold is used to delineate emphysematous from nonemphysematous tissue. This measure can be expressed as a fraction but is most commonly reported as the percent low attenuation areas ( <em>LAA</em> %) . Although easy to use for correlative investigation, the <em>LAA</em> % does not fully assess the heterogeneous nature of emphysema or its subtypes.</p><p>The clinical significance of six features that capture the prevalence of emphysema subtypes (normal tissue [NT]; paraseptal; panlobular; and mild, moderate, and severe centrilobular emphysema) has been previously demonstrated. It has also been shown that these features provide complementary information to <em>LAA</em> % . However, it becomes increasingly difficult to perform regression analysis as the number of features increases. In addition, it is difficult to appreciate how a variable mixture of these features results in the same level of disease severity. It would therefore be useful to aggregate these multiple features into a single measure without losing information about the individual subtypes. However, currently available methods for the quantification of emphysema on computed tomography (CT) images either do not quantify severity based on emphysema subtypes or suffer from low performance and inter-scanner variability.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="population"><span class="mr-2">Population</span><a href="#population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Distribution of <em>S</em> and <em>LAA</em> % Across GOLD Stages</p><p>Nonsmoking Normal Subjects Reduced <em>FEV</em> 1 and FVC GOLD 0 GOLD 1 GOLD 2 GOLD 3 GOLD 4 Variable Train Test Train Test Train Test Train Test Train Test Train Test Train Test n = 0 n = 102 n = 213 n = 804 n = 931 n = 2788 n = 203 n = 505 n = 491 n = 1171 n = 315 n = 660 n = 172 n = 292 Men/Women — 33/69 103/110 359/445 449/482 1487/1301 105/98 259/246 184/307 537/634 72/243 198/462 16/156 34/258 Age at enrollment — 60.7 ± 10.3 60.7 ± 8.9 60.1 ± 9.2 58.9 ± 9.1 59.5 ± 9.2 59.4 ± 9.2 58.9 ± 8.7 59.6 ± 8.8 59.7 ± 9.2 60.7 ± 9.0 60.5 ± 9.0 61.2 ± 8.7 61.2 ± 9.1 BMI (kg/m 2 ) — 28.4 ± 5.1 31.2 ± 7.3 31.5 ± 7.1 28.5 ± 5.8 29.0 ± 5.7 26.7 ± 4.9 27.0 ± 4.8 28.9 ± 6.0 28.7 ± 6.1 27J ± 6.2 28.1 ± 6.3 25.2 ± 5.5 24.9 ± 5.5 Current smoker — 0/102 114/99 519/285 489/442 1666/1122 119/84 315/190 296/195 739/432 244/71 499/161 154/18 263/29 Total lung capacity — 5.4 ± 1.2 4.6 ± 1.1 4.5 ± 1.1 5.4 ± 1.3 5.4 ± 1.3 6.2 ± 1.5 6.1 ± 1.4 5.7 ± 1.4 5.8 ± 1.4 6.1 ± 1.4 6.3 ± 1.5 6.6 ± 1.4 7.0 ± 1.5<em>LAA</em> % — 1.9 ± 2.5 1.7 ± 1.9 1.4 ± 2.4 2.6 ± 2.9 1.8 ± 2.4 6.7 ± 6.3 4.7 ± 5.3 8.4 ± 7.9 6.6 ± 7.5 18.0 ± 12.7 15.2 ± 12.2 27.7 ± 13.7 26.4 ± 14.2<em>FEV</em> 1pp — 103.0 ± 13.7 70.6 ± 8.0 70.7 ± 7.9 98.0 ± 11.8 97.5 ± 11.4 91.4 ± 9.3 90.6 ± 8.9 64.9 ± 8.6 65.3 ± 8.4 40.0 ± 5.7 40.4 ± 5.7 22A ± 4.8 23.0 ± 4.6 ATS pack-years — 39.5 ± 21.0 48.4 ± 28.1 43.7 ± 24.9 43.1 ± 24.4 44.0 ± 25.1 44.8 ± 24.2 44.7 ± 24.8 43.5 ± 23.0 46.2 ± 26.6 43.8 ± 24.9 45.4 ± 25.9 46.4 ± 26.5 45.3 ± 27.2</p><p>BMI, body mass index; <em>FEV</em> 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for Obstructive Lung Disease; <em>LAA</em> %, percent low attenuation areas.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-protocols"><span class="mr-2">CT Protocols</span><a href="#ct-protocols" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="emphysema-subtype-features"><span class="mr-2">Emphysema Subtype Features</span><a href="#emphysema-subtype-features" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/0_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/0_1s20S1076633216000556.jpg" alt="Figure 1, Computed tomography (CT) slices ( top row ) and their corresponding emphysema classification ( bottom row ). Slices from three patients are shown and range from mild ( left ) to severe ( right ). The emphysema classes have the following color codes: normal parenchyma is red, paraseptal emphysema is green, panlobular emphysema is blue, mild centrilobular emphysema is yellow, moderate centrilobular emphysema is cyan, and severe centrilobular emphysema is purple." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="severity-index-from-ct-image-information"><span class="mr-2">Severity Index From CT Image Information</span><a href="#severity-index-from-ct-image-information" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/1_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/1_1s20S1076633216000556.jpg" alt="Figure 2, Derivation of the severity measure S from the local histogram emphysema space. The data are projected onto the two spaces shown. Cyan, black, blue, green, and red represent cases with Global Initiative for Obstructive Lung Disease (GOLD) stages 0, 1, 2, 3, and 4, respectively; magenta is for cases with reduced forced expiratory volume in 1 second ( FEV 1 ) and forced vital capacity (FVC)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>in the models for distance walked and SGRQ, and adjusted for age, gender, race, height, smoking status, and number of pack-years in the model for <em>FEV</em> 1 .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="analysis-of-severity"><span class="mr-2">Analysis of Severity</span><a href="#analysis-of-severity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/2_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/2_1s20S1076633216000556.jpg" alt="Figure 3, Distribution of S and percent low attenuation areas ( LAA %) across Global Initiative for Obstructive Lung Disease (GOLD). A gray line shows the mean over all the data. (Color version of figure is available online)." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Statistics for <em>S</em> and <em>LAA</em> % Across GOLD Stages</p><p>Statistic Emphysema Measure Nonsmoking Normal Subjects Reduced <em>FEV</em> 1 and FVC GOLD 0 GOLD 1 GOLD 2 GOLD 3 GOLD 4 Mean_S_ 4.38 5.30 4.92 6.55 8.36 11.87 14.76<em>LAA</em> % 1.92 1.36 1.81 4.74 6.55 15.16 26.36 Minimum_S_ 0.61 0.15 −0.02 1.04 0.50 0.29 1.81<em>LAA</em> % 0.02 0.00 0.00 0.02 0.02 0.02 0.13 Maximum_S_ 14.96 19.63 17.27 22.70 20.41 21.65 21.13<em>LAA</em> % 13.24 33.80 25.88 42.95 41.44 53.50 61.91 Coefficient of variation_S_ 65.16 54.84 55.89 55.14 51.80 39.32 27.26<em>LAA</em> % 129.63 177.92 131.96 112.51 114.81 80.31 53.80</p><p><em>FEV</em> 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for Obstructive Lung Disease; <em>LAA</em> %, percent low attenuation areas.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/3_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/3_1s20S1076633216000556.jpg" alt="Figure 4, R 2 between percent low attenuation areas ( LAA %) and S across Global Initiative for Obstructive Lung Disease (GOLD) stages. (Color version of figure is available online)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/4_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/4_1s20S1076633216000556.jpg" alt="Figure 5, Distribution of S and percent low attenuation areas ( LAA %) across expert scores. A gray line shows the mean over all the data." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="associations-with-outcomes"><span class="mr-2">Associations With Outcomes</span><a href="#associations-with-outcomes" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/5_1s20S1076633216000556.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ARobustEmphysemaSeverityMeasureBasedonDiseaseSubtypes/5_1s20S1076633216000556.jpg" alt="Figure 6, Distribution of forced expiratory volume in 1 second ( FEV 1 ) and S for the testing data. (Color version of figure is available online.)" class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Univariate Regression Models for each of the Outcomes. Either <em>S</em> or <em>LAA</em> % Is Used in each Model</p><p>Outcome Variable in Model Adjusted R-Squared Coeff. of Variation Parameter Estimate Standard Error Pr &gt; |t|<em>FEV</em> 1 S 0.2382 34.08072 −0.09773 0.00222 &lt;0.0001<em>LAA</em> % 0.2215 34.45309 −0.04721 0.00112 &lt;0.0001 Six-minute walk S 0.1004 26.24787 −8.19542 0.31094 &lt;0.0001<em>LAA</em> % 0.0674 26.72477 −3.36491 0.15859 &lt;0.0001 SGRQ S 0.1138 80.33368 1.69611 0.05997 &lt;0.0001<em>LAA</em> % 0.0993 80.99069 0.79356 0.03029 &lt;0.0001</p><p><em>FEV</em> 1 , forced expiratory volume in 1 second; <em>LAA</em> %, percent low attenuation areas; SGRQ, St. George’s Respiratory Questionnaire.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Multivariate Regression Models for each of the Outcomes Controlling for Covariates</p><p>Outcome Adjusted R-Squared Coeff. of Variation Variable Parameter Estimate Standard Error Pr &gt; |t|<em>FEV</em> 1 0.5868 25.09844 S −0.04202 0.0029 &lt;0.0001<em>LAA</em> % −0.02687 0.0014 &lt;0.0001 Six-minute walk 0.3259 22.72081 S −1.75754 0.5125 0.0006<em>LAA</em> % −1.09679 0.2639 &lt;0.0001 SGRQ 0.3491 68.85068 S 0.44639 0.09786 &lt;0.0001<em>LAA</em> % 0.2555 0.05039 &lt;0.0001</p><p><em>FEV</em> 1 , forced expiratory volume in 1 second; LAA%, percent low attenuation areas; SGRQ, St. George’s Respiratory Questionnaire.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="appendix"><span class="mr-2">Appendix</span><a href="#appendix" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="supplementary-material"><span class="mr-2">Supplementary material</span><a href="#supplementary-material" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Appendix S1</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Muller N.L., Staples C.A., Miller R.R., et. al.: “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest 1988; 94: pp. 782-787.</p><li><p>2. Mendoza C.S., Washko G.R., Ross J.C., et. al.: Emphysema quantification in a multi-scanner hrct cohort using local intensity distributions. Proc IEEE Int Symp Biomed Imaging 2012; 88: pp. 474-477.</p><li><p>3. Hara T., Yamamoto A., Zhou X., et. al.: Automated detection system for pulmonary emphysema on 3D chest CT images. Proc SPIE Int Soc Opt Eng 2004; 5370: pp. 915-919.</p><li><p>4. Xu Y., Sonka M., McLennan G., et. al.: MDCT-based 3-D texture classification of emphysema and early smoking related lung pathologies. IEEE Trans Med Imaging 2006; 25: pp. 464-475.</p><li><p>5. Uppaluri R., Mitsa T., Sonka M., et. al.: Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997; 156: pp. 248-254.</p><li><p>6. Depeursinge A., Sage D., Hidki A., et. al.: Lung tissue classification using wavelet frames. Conf Proc IEEE Eng Med Biol Soc 2007; 2007: pp. 6259-6262.</p><li><p>7. Park Y., Seo J.B., Kim N., et. al.: Texture-based quantification of pulmonary emphysema on high-resolution computed tomography: comparison with density-based quantification and correlation with pulmonary function test. Invest Radiol 2008; 43: pp. 395-402.</p><li><p>8. Dharmagunawardhana C., Mahmoodi S., Bennett M., et. al.: Quantitative analysis of pulmonary emphysema using isotropic Gaussian Markov random fields.9th International Conference on Computer Vision Theory and Applications.2014.pp. 44-53.</p><li><p>9. Hame Y., Elsa A., Hoffman E., et. al.: Adaptive quantification and longitudinal analysis of pulmonary emphysema with a hidden Markov measure field model. EEE Trans Med Imaging 2014; 33: pp. 1527-1540.</p><li><p>10. Duda R.O., Hart P.E., Stork D.G., et. al.: Pattern classification.2nd ed.2001.</p><li><p>11. Regan E., Hokanson J., Murphy J., et. al.: Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7: pp. 32-43.</p><li><p>12. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med1995.pp. 1107-1136. 152</p><li><p>13. Jones P.W., Quirk F.H., Baveystock C.M.: The St. George’s Respiratory Questionnaire. Respir Med 1991; 85: pp. 25-31.</p><li><p>14. Diaz A., Han M.K., Come C.E., et. al.: Effect of emphysema on CT scan measures of airway dimensions in smokers. Chest 2013; 143: pp. 687-693.</p><li><p>15. Jolliffe I.T.: Principal component analysis.Lovric M.International encyclopedia of statistical science.2011.SpringerNew York:pp. 1094-1096.</p><li><p>16. McLachlan G.J.: Discriminant analysis and statistical pattern recognition, Wiley series in probability and mathematical statistics.1992.J. Wiley and SonsNew York, Chichester, Brisbane</p><li><p>17. Martinez C.H., Chen Y.-H., Westgate P.M., et. al.: Relationship between quantitative CT metrics and health status and bode in chronic obstructive pulmonary disease. Thorax 2012; 67: pp. 399-406.</p><li><p>18. Rambod M., Porszasz J., Make B.J., et. al.: Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort. Chest 2012; 141: pp. 867-875.</p><li><p>19. Cho M.H., Castaldi P.J., Hersh C.P., et. al.: A genome-wide association study of emphysema and airway quantitative imaging phenotypes. Am J Respir Crit Care Med 2015; 192: pp. 559-569.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=A%20Robust%20Emphysema%20Severity%20Measure%20Based%20on%20Disease%20Subtypes%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fa-robust-emphysema-severity-measure-based-on-disease-subtypes%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=A%20Robust%20Emphysema%20Severity%20Measure%20Based%20on%20Disease%20Subtypes%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fa-robust-emphysema-severity-measure-based-on-disease-subtypes%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fa-robust-emphysema-severity-measure-based-on-disease-subtypes%2F&text=A%20Robust%20Emphysema%20Severity%20Measure%20Based%20on%20Disease%20Subtypes%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-resident-perspective-on-adding-value-as-radiologists/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Resident Perspective on Adding Value as Radiologists</h3><div class="text-muted small"><p> During the annual 46th annual American Alliance of Academic Chief Residents in Radiology (A 3 CR 2 ) meeting in New Orleans, chief residents discussed the role of residents within American Colleg...</p></div></div></a></div><div class="card"> <a href="/posts/bi-rads-density-classification-from-areometric-and-volumetric-automatic-breast-density-measurements/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>BI-RADS Density Classification From Areometric and Volumetric Automatic Breast Density Measurements</h3><div class="text-muted small"><p> Rationale and Objectives The aim of our study was to classify breast density using areometric and volumetric automatic measurements to best match Breast Imaging-Reporting and Data System (BI-RADS)...</p></div></div></a></div><div class="card"> <a href="/posts/coronary-computed-tomographic-angiography-at-low-concentration-of-contrast-agent-and-low-tube-voltag/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Coronary Computed Tomographic Angiography at Low Concentration of Contrast Agent and Low Tube Voltage in Patients with Obesity</h3><div class="text-muted small"><p> Rationale and Objectives Using lower tube voltage can reduce the exposure to radiation and the dose of contrast agent. However, lower tube voltage is often linked to more noise and poor image qual...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/a-resident-perspective-on-adding-value-as-radiologists/" class="btn btn-outline-primary" prompt="Older"><p>A Resident Perspective on Adding Value as Radiologists</p></a> <a href="/posts/bi-rads-density-classification-from-areometric-and-volumetric-automatic-breast-density-measurements/" class="btn btn-outline-primary" prompt="Newer"><p>BI-RADS Density Classification From Areometric and Volumetric Automatic Breast Density Measurements</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
